When too many red blood cells thicken the blood, circulation can slow and clots may form in arteries or veins. See how high hematocrit affects blood flow, why thrombosis is a key concern, and how this risk differs from heart strain or other clotting disorders.

Multiple Choice

A complication associated with polycythemia due to hyperviscosity is which of the following?

When hematocrit is high, blood becomes more viscous, which slows flow, especially in the microcirculation. This sluggish flow promotes stasis and activates coagulation pathways, making clot formation more likely in both arteries and veins. That combination—hyperviscosity leading to impaired perfusion and increased thrombotic risk—is the hallmark complication of polycythemia related to the thickened blood, so thrombosis is the best answer. While polycythemia can strain the heart and, in some cases, contribute to edema, and while DIC is a separate coagulopathy, they are not the classic hyperviscosity-related complication.

Polycythemia and the Hidden Risk of Thickened Blood

Blood needs to flow freely. When it becomes unusually thick, even the heart’s steady pumping may not be enough to keep circulation moving smoothly. In polycythemia, an increase in red blood cells can raise blood viscosity—the measure of how resistant a fluid is to flow. This change can slow circulation and raise the risk of thrombosis, or blood clots forming inside blood vessels.

That risk is one of the most important complications to understand in hematology. A clot can block blood flow where it forms, or break loose and travel to another part of the body. Either way, the result can be serious. The details depend on what caused the polycythemia, how high the blood cell levels are, and a person’s other health risks.

What does polycythemia mean?

Polycythemia describes an increase in red blood cells. These cells contain hemoglobin, which carries oxygen from the lungs to the body’s tissues. A higher-than-usual red blood cell level may sound helpful at first: more cells might seem to mean more oxygen delivery. But the body’s circulation is a balancing act. Too many cells can make blood thicker and harder to move through small vessels.

The term can refer to more than one condition. Polycythemia vera is a chronic bone marrow disorder in which the marrow makes too many blood cells, often including red cells, platelets, and white blood cells. It is commonly linked to a change in the JAK2 gene. Secondary erythrocytosis, sometimes called secondary polycythemia, develops when another factor prompts the body to make extra red blood cells. Low oxygen levels, certain lung or heart conditions, smoking, and some medications are among the possible causes.

There’s also a relative increase in red blood cell concentration. In this case, the body may have less plasma—the liquid part of blood—rather than a true increase in red cell production. Dehydration can contribute. That distinction matters because the cause shapes both the evaluation and the care plan.

Why thick blood raises clot risk

Imagine trying to pour honey through a narrow straw. It moves, but not as easily as water. Blood isn’t honey, of course, but the comparison helps explain viscosity. When hematocrit—the share of blood volume made up of red cells—rises, blood may become more resistant to flow.

Slower flow can allow blood to pool or stagnate, especially in smaller vessels. Stasis is one factor that can encourage clot formation. Changes in blood vessel walls and the balance of clotting factors also matter. In polycythemia vera, the elevated red cell count is only part of the picture: platelets and white blood cells may also be involved, and the cells may interact with vessel walls in ways that add to clot risk.

Clots can form in veins or arteries. A deep vein thrombosis often develops in a leg, though it can occur elsewhere. If part of the clot travels to the lungs, it can cause a pulmonary embolism. In arteries, a clot may interrupt blood supply to the brain or heart, contributing to a stroke or heart attack. The location shapes the symptoms, but the underlying concern is the same: vital tissue may not receive enough blood and oxygen.

The warning signs aren’t always dramatic

Some people with polycythemia have few symptoms at first. Others notice headaches, dizziness, blurred vision, ringing in the ears, or unusual fatigue. These symptoms can have many causes, so they don’t confirm polycythemia on their own. A clinician may also find a ruddy complexion, an enlarged spleen, or high blood pressure.

Clot symptoms depend on where the clot forms. A leg clot may cause swelling, pain, warmth, or redness, often on one side. Sudden shortness of breath, chest pain, coughing up blood, or a rapid heartbeat can signal a pulmonary embolism and calls for urgent medical care. Sudden weakness on one side, trouble speaking, facial drooping, or new confusion may indicate a stroke. Chest pressure or pain can signal a heart problem.

These warning signs should be taken seriously, but not every ache or headache points to a clot. The key is to respond quickly to sudden, severe, or unusual symptoms rather than trying to sort them out alone.

How clinicians investigate the cause

A complete blood count is often the first clue. It measures red blood cells, hemoglobin, hematocrit, white blood cells, and platelets. If results are high, a clinician may repeat the test and consider factors such as hydration, oxygen levels, smoking history, medications, and symptoms.

Further evaluation depends on the pattern. Tests may include oxygen measurement, blood tests for erythropoietin, and testing for a JAK2 mutation. Erythropoietin is a hormone that signals the bone marrow to make red blood cells. Its level can help clinicians distinguish possible causes, although it is interpreted alongside other findings.

The point isn’t simply to label a high number. It’s to understand why it is high. A person whose red cell level rises due to a treatable source of low oxygen needs a different approach from someone with polycythemia vera, a long-term bone marrow condition.

Reducing risk and treating the underlying problem

Treatment is tailored to the cause and the person’s overall health. For polycythemia vera, clinicians may use phlebotomy, which removes a measured amount of blood, to lower hematocrit. Some people may also receive medication to reduce blood cell production. Low-dose aspirin may be recommended in certain cases, but it is not suitable for everyone; bleeding risk and other health factors need to be considered.

Secondary erythrocytosis is managed by addressing its cause where possible. That might mean evaluating a breathing or heart condition, reviewing a medication, or supporting smoking cessation. Simply lowering the red cell count without understanding the reason can miss the problem driving it.

Everyday steps can support circulation, too. Staying hydrated is sensible for many people, and avoiding tobacco benefits blood vessels and oxygen delivery. But lifestyle measures do not replace medical evaluation, especially when blood counts are persistently high or symptoms appear. Care should be guided by a clinician familiar with the person’s diagnosis.

A small change in flow can matter

Polycythemia shows how a change in blood composition can affect the whole circulatory system. More red cells may sound like a straightforward gain, but thicker blood can move less smoothly and make thrombosis more likely. That risk is especially important in polycythemia vera, though the causes and degree of risk vary from person to person.

Knowing the signs, identifying the underlying cause, and choosing treatment accordingly can help reduce complications. Blood may look simple in a lab tube. Inside the body, its flow depends on a delicate balance—and that balance is worth protecting.